StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a report released on Wednesday. The brokerage issued a hold rating on the software maker’s stock.
Separately, Stephens lifted their target price on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Friday, January 31st.
Check Out Our Latest Stock Report on MDRX
Veradigm Stock Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- Consumer Discretionary Stocks Explained
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- What is Forex and How Does it Work?
- The 3 Most Talked About Investments on WallStreetBets Right Now
- What is the Nasdaq? Complete Overview with History
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.